Skip to main content

Cultivated Adult Stem Cells as Alternative for Damaged tissue

Ziel

Rapid progress in stem cell research pave the way for the development and use of new cell therapy products in regenerative medicine. The objective of CASCADE is to provide the European Community with unique expertise which focuses on the GMP production of mesenchymal stem cells (MSC) and their use in treating skin and corneal wounds, so that quality and safety criteria are paramount and match therapeutic expectations. Commencing with known procedures, CASCADE will develop innovative technologies based on the expertise of its partners. Among our research themes, the specific issue of multiple recipients and universal donors will be investigated. To this end, human MSC will be derived from 4 tissues, bone marrow, fat tissue, cord blood and amniotic membrane, according to good manufacturing practice (GMP). Phenotypic identity of GMP produced MSC, their genetic status and their potential for transformation will constitute the basis for establishing standards for controlling cell production. The efficacy of GMP produced MSC will be tested in in vitro and in vivo models, and the immunological consequences of their use will be studied. Moreover, during the whole CASCADE initiative, ethical and legal issues raised as a result of MSC therapies will be considered. Direct collaboration with two clinical networks will allow CASCADE to finely tune production specifications, and define optimal clinical protocols for these MSC-based cellular therapies. CASCADE will therefore gather together leading European cell therapy laboratories with unrivalled expertise in the production of therapeutic cells and in MSC biology, four SMEs with specific know-how in GMP production of cells and two clinical networks in dermatology and ophthalmology. The outcome will be a consortium that encompasses all the technologies and skills required to efficiently develop innovative technologies for the production of clinical grade MSC and to translate this production into a cell drug to repair wounds.

Aufforderung zur Vorschlagseinreichung

FP7-HEALTH-2007-B
Andere Projekte für diesen Aufruf anzeigen

Koordinator

ETABLISSEMENT FRANCAIS DU SANG
Adresse
Avenue Du Stade De France 20
93210 La Plaine Saint Denis
Frankreich
Aktivitätstyp
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
EU-Beitrag
€ 430 000
Kontakt Verwaltung
Laurent Beauverger (Mr.)

Beteiligte (15)

DRK-BLUTSPENDEDIENST BADEN-WURTTEMBERG-HESSEN GGMBH
Deutschland
EU-Beitrag
€ 599 414
Adresse
Friedrich Ebert Strasse 107
68167 Mannheim
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Hubert Schrezenmeier (Prof.)
FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO
Italien
EU-Beitrag
€ 204 578
Adresse
Via Francesco Sforza 28
20122 Milano
Aktivitätstyp
Other
Kontakt Verwaltung
Rosaria Giordano (Dr.)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Frankreich
EU-Beitrag
€ 243 725
Adresse
Rue De Tolbiac 101
75654 Paris
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Annick Bertault (Ms.)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Frankreich
EU-Beitrag
€ 115 243
Adresse
Rue Michel Ange 3
75794 Paris
Aktivitätstyp
Other
Kontakt Verwaltung
Armelle Barelli (Ms.)
UNIVERSITA DEGLI STUDI DI VERONA
Italien
EU-Beitrag
€ 152 800
Adresse
Via Dell Artigliere 8
37129 Verona
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Mauro Krampera (Dr.)
UNIVERSITATEA DE MEDICINA SI FARMACIE VICTOR BABES TIMISOARA
Rumänien
EU-Beitrag
€ 132 000
Adresse
Piata Eftimie Murgu 2A
300041 Timisoara
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Constanta Caplar (Ms.)
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom
EU-Beitrag
€ 143 000
Adresse
Wellington Square University Offices
OX1 2JD Oxford
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Samantha Hatzis (Ms.)
THE UNIVERSITY OF SHEFFIELD
United Kingdom
EU-Beitrag
€ 80 000
Adresse
Firth Court Western Bank
S10 2TN Sheffield
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Gill Wells (Ms.)
ABCELL-BIO Sarl
Frankreich
EU-Beitrag
€ 135 000
Adresse
Rue Taitbout 85
75009 Paris
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Jean-Pierre Mouscadet (Mr.)
ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
Frankreich
EU-Beitrag
€ 74 999
Adresse
Rue Francaise 4
75001 Paris
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Denis Barritault (Prof.)
BIOTRACK SRL
Italien
EU-Beitrag
€ 120 249
Adresse
Via Einstein 1
26900 Lodi
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Elisa Filippi (Dr.)
UNIVERSITAT DES SAARLANDES
Deutschland
EU-Beitrag
€ 123 000
Adresse
Campus
66123 Saarbrucken
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Mareike Schmitt (Ms.)
UNIVERSITAET ULM
Deutschland
EU-Beitrag
€ 142 798
Adresse
Helmholtzstrasse 16
89081 Ulm
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Frank Gleixner (Mr.)
UNIVERSITATSKLINIKUM HEIDELBERG
Deutschland
EU-Beitrag
€ 83 000
Adresse
Im Neuenheimer Feld 672
69120 Heidelberg
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Thorsten Brietz
ALCIMED
Frankreich
EU-Beitrag
€ 199 861
Adresse
Boulevard De Montmorency 57
75016 Paris
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
David Bariau (Mr.)